Symbol: CIPLA
Month: 2024-03
Start Price: ₹1458.53
End Price: ₹1484.36
12M Return: 1.77%
6M Return: 1.77%
3M Return: 1.77%
Volatility: 0.259
Sharpe Ratio: 1.129
Max Drawdown: -0.058
Peer Correlation (SUNPHARMA): 0.5826
Peer Correlation (DIVISLAB): 0.5182
Peer Correlation (GRASIM): 0.7541
Average Peer Correlation: 0.6183

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Cipla (CIPLA) has demonstrated a steady performance in the past 12 months, with a return of 1.77%. The stock's volatility is relatively low at 0.259, and its Sharpe Ratio of 1.129 indicates a good risk-adjusted return. The maximum drawdown of -0.058 suggests that the stock has been resilient to market downturns. In terms of peer correlation, CIPLA has a moderate correlation with SUNPHARMA and DIVISLAB, but a high correlation with GRASIM, with an average peer correlation of 0.6183.

**Recommendation:**

Based on the analysis, I would suggest a **BUY** recommendation for CIPLA. The stock's consistent performance, low volatility, and good risk-adjusted return make it an attractive investment opportunity. Additionally, the moderate correlation with peers suggests that CIPLA has the potential to outperform its peers in the industry. With a relatively low maximum drawdown, the stock appears to be a stable investment option. Overall, CIPLA's fundamental and technical indicators suggest a buy signal, making it a good addition to a diversified portfolio.